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Background:  In 2009,  Thailand  recommended  pregnant  women  be prioritized  for inﬂuenza  vaccination.
Vaccine  uptake  among  Thai  pregnant  women  is lower  than  other  high-risk  groups.
Methods:  During  December  2012–April  2013,  we  conducted  a cross-sectional  survey  of  a  convenience
sample  of  Thai pregnant  women  aged  ≥15  years  attending  antenatal  clinics  at public  hospitals  in  8  of
77  provinces.  A self-administered  questionnaire  covered  knowledge,  attitudes,  and  beliefs  related  to
inﬂuenza  vaccination  using  the  Health  Belief  Model.  We examined  factors  associated  with  willingness  to
be vaccinated  using  log-binomial  regression  models.
Results:  The  survey  was  completed  by 1031  (96%)  of  1072  pregnant  women  approached.  A  total  of 627
(61%)  women  had  heard  about  inﬂuenza  vaccine  and were  included  in  the  analysis,  of whom  262 (42%)
were  willing  to  be vaccinated,  155  (25%)  had  received  a  healthcare  provider  recommendation  for  inﬂuenza
vaccination  and 25  (4%)  had  received  the  inﬂuenza  vaccine  during  the  current  pregnancy.  In unadjusted
models,  high  levels  of perceptions  of  susceptibility  (prevalence  ratio  [PR]  1.5,  95%  CI 1.2–2.0),  high  levels
of belief  in the  beneﬁts  of  vaccination  (PR 2.3,  95%  CI 1.7–3.1),  moderate  (PR  1.7,  95%  CI  1.2–2.3)  and
high  (PR  3.4, 95% CI  2.6–4.5)  levels  of encouragement  by  others  to  be vaccinated  (i.e., cues to  action)
were  positively  associated  with  willingness  to  be vaccinated.  Moderate  (PR  0.5, 95%  CI  0.4–0.7)  and  high
levels  of  (PR  0.5,  95%  CI  0.4–0.8)  perceived  barriers  were  negatively  associated  with  willingness  to be
vaccinated.  In the  ﬁnal  adjusted  model,  only  moderate  (PR  1.5,  95%  CI 1.1–2.0)  and high levels  of  cues  to
action  (PR  2.7, 95% CI 2.0–3.6)  were  statistically  associated  with  willingness  to  be vaccinated.
Conclusion:  Cues  to action  were  associated  with  willingness  to  be  vaccinated  and  can  be used  to  inform
communication  strategies  during  the  vaccine  campaign  to increase  inﬂuenza  vaccination  among  Thai
pregnant  women.
Published  by  Elsevier  Ltd. This  is  an  open  access  article  under  the CC BY-NC-ND  license  (http://. Introduction
Inﬂuenza is an important cause of morbidity and mortality
orldwide, and pregnant women are at increased risk of severe
omplications compared with the non-pregnant population [1,2].
uring the 2009 inﬂuenza A(H1N1) pandemic, hospitalized and
ntubated patients with inﬂuenza were signiﬁcantly more likely
o be pregnant women compared to community controls [3].
∗ Corresponding author.
E-mail address: charungm@hotmail.com (C. Muangchana).
ttp://dx.doi.org/10.1016/j.vaccine.2016.01.056
264-410X/Published by Elsevier Ltd. This is an open access article under the CC BY-NC-Ncreativecommons.org/licenses/by-nc-nd/4.0/).
The mortality rate among pregnant women  from inﬂuenza and
pneumonia during the 2009 pandemic was  2- to 3- fold higher
than among non-pregnant women  [4–6], and women  who  died
were more likely to be pregnant than those who did not [6].
Inﬂuenza vaccination is the most effective strategy for pre-
venting illness associated with inﬂuenza infection and reducing
inﬂuenza-related complications [7,8]. Vaccination during preg-
nancy provides beneﬁts to both mother and newborn [9,10].
A randomized controlled trial and a prospective cohort study
both found that maternal inﬂuenza vaccination was effective at
preventing laboratory-conﬁrmed inﬂuenza in infants up to six
months of age, who are not yet eligible for inﬂuenza vaccination
D license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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10,11]. Maternal vaccination is also associated with a reduced
isk of inﬂuenza-associated hospitalizations in infants less than six
onths old [12,13].
In 2009, the Thai Advisory Committee on Immunization
ractices recommended seasonal inﬂuenza vaccine for pregnant
omen in the second and third trimester of pregnancy as a high
riority group, after which the vaccine was made available free of
harge through the Universal Coverage Scheme (a national health
nsurance available to all Thais) [14,15]. The amount of vaccine
vailable is far less than needed for all recommended high risk
roups, and between 2010 and 2012, coverage of seasonal inﬂuenza
accine in pregnant women was less than 1% and far lower than
ther high risk groups [14]. The reasons for the low uptake of
nﬂuenza vaccine among pregnant women in Thailand are not
nown, and the knowledge, attitudes and health beliefs of pregnant
omen in Thailand about seasonal inﬂuenza vaccination have not
een investigated extensively. Understanding how these factors
ffect inﬂuenza vaccination would improve communication cam-
aigns directed at pregnant women’s awareness of the beneﬁts
f inﬂuenza vaccination and concerns regarding vaccine safety. In
his evaluation, we identiﬁed factors among pregnant women that
ere associated with willingness to receive the seasonal inﬂuenza
accine.
. Methods
During December 2012–April 2013, we conducted a cross-
ectional survey among a convenience sample of pregnant Thai
omen who attended antenatal clinics (ANCs) at public hospitals.
n Thailand, the largest inﬂuenza virus activity peaks between June
nd October [16] and therefore the inﬂuenza vaccine campaign
uns between May  and September each year [14]. We  purposively
elected seven provinces plus the Bangkok Metropolitan Area to
raw from the four regions of Thailand (central, northern, southern
nd northeastern). We selected the provincial hospital and three
istrict hospitals from each province, and the only government
aternity hospital plus three health centers from the Bangkok
etropolitan area. We  allocated a target number of women for
nrolment to each hospital and health center in advance with
n overall enrolment goal of 1072 women. The ANC clinics are
sually open one to two days per week, and surveys were only
dministered on days during which ANC clinics were open. Study
taff approached pregnant women who visited ANC clinics and
btained verbal consent from all pregnant women before admin-
stering the survey. Surveys were conducted on multiple days in
rder to reach the sample size for each hospital. Women  were eli-
ible for participation if they were of Thai nationality, aged ≥15
ears, could read and write Thai and provided verbal consent.
s the survey was evaluating a national public health program,
t was considered program evaluation and exempted from eth-
cal review by the Thai Ministry of Public Health (Nonthaburi,
hailand) and the U.S. Centers for Disease Control and Prevention
Atlanta, GA).
The questionnaire requested demographic information, his-
ory of previous inﬂuenza vaccination and knowledge of inﬂuenza
irus infection and vaccination. Questions related to attitudes
owards inﬂuenza vaccination were based on the Health Belief
odel (HBM)which includes ﬁve constructs that inﬂuence health
ehaviors, namely perceptions of susceptibility, severity, barriers,
eneﬁts, and cues to action [17]. The HBM posits that people are
ikely to exhibit disease prevention behaviors (such as vaccina-
ion) if they perceive that they are susceptible to the disease, the
isease is severe, the behavior is beneﬁcial, and barriers are mini-
al  [18]. In addition, cues to action, such as recommendations of
ealth care providers or health messages, can affect behaviors. We
dapted and modiﬁed questions from previous published literature 34 (2016) 2141–2146
[18,19] and translated them into the Thai language. Two statements
in the questionnaire focused on perceived susceptibility to getting
inﬂuenza for both mother and infant; two on perceived severity
of inﬂuenza infection for mother and infant; three on perceived
barriers of inﬂuenza vaccine; three on perceived beneﬁts of the
vaccine; and ﬁve on cues to action (i.e., encouragement by others
to be vaccinated).
Participants who  had never heard of the inﬂuenza vaccine
were excluded from analysis of factors affecting vaccination since
our study was designed to assess pre-existing attitudes towards
inﬂuenza vaccination. Among the women who had heard of the
inﬂuenza vaccine, those who reported having received an inﬂuenza
vaccine or reported that they wanted to get the inﬂuenza vaccine
during their current pregnancy were considered willing to be vac-
cinated. We  grouped response answer for HBM individual items
into two  groups: (1) agree, or (2) disagree or don’t know/not sure.
Participants’ level of concern about their personal susceptibility to
inﬂuenza during this pregnancy and their unborn child’s suscepti-
bility were categorized as (1) moderate or very concerned, or (2)
little or not concerned or don’t know. We compared the proportion
of women  who  agreed with the statements or were moderately
or very concerned between women willing and unwilling to be
vaccinated using a Chi-square test.
Individual HBM items were re-coded to three levels (Supple-
mental Table 1) such that higher values corresponded to a greater
degree of agreement or importance as: 1 = unlikely, low or disagree;
2 = uncertain or moderate, and 3 = likely, high or agree [20]. The
individual HBM items were combined based on conceptual similar-
ity into HBM constructs and then summed to create scores for each
component of the HBM framework. In order to facilitate interpreta-
tion, participants were divided into tertiles by their summed score
to create three (low/moderate/high) categories for each HBM con-
struct, with the exception of perceived severity which was  scored
dichotomously (low/high) given the high kurtosis (peakedness) of
the distribution [20].
The associations between demographic characteristics and HBM
constructs with willingness to be vaccinated were analyzed using
a log-binomial model with a generalized estimating equations
approach. Standard errors were adjusted for data clustered by hos-
pital using a robust sandwich estimator with an exchangeable
correlation structure; prevalence ratios (PR) and 95% conﬁdence
intervals (CI) were calculated. All HBM constructs plus any patient
characteristic variables statistically associated with willingness to
be vaccinated (P < 0.05) were included in the multivariable model-
ing process, although variables highly correlated with the outcome
(such as previous history of vaccination) were excluded. Model
selection proceeded by backward step selection to identify the set
of parameters that minimized the quasi-likelihood information cri-
terion [21]. All statistical analyses were performed with SPSS (IBM
SPSS Statistic 20).
3. Results
3.1. Demographic characteristics of pregnant women and
willingness to be vaccinated
Of 1072 pregnant women approached from 32 facilities, 1031
(96%) completed the questionnaire. Of these 1031 women, 627
(61%) had heard about the inﬂuenza vaccine and were considered
the analytical sample (Fig. 1). Women  who  had heard about the
inﬂuenza vaccine were more likely to be educated (PR 1.7, 95% CI
1.4–2.0), aged 25–34 years (PR 1.4, 95% CI 1.3–1.6), aged 35–45
years (PR 1.4, 95% CI 1.2–1.6), have universal health insurance (PR
1.8, 95% CI 1.2–2.7), have received inﬂuenza vaccine during a previ-
ous pregnancy (PR 1.3, 95% CI 1.2–2.7), and have received inﬂuenza
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a Willing to receive the vac cine: preg nant women who responded “yes ” to one of the following 
quesons: “Did you receive  inﬂ uenz a va ccine du ring this  pregnancy?” or “Do you want to get 
inﬂ uenza va ccine or not?”
b Not willi ng to receive the va ccine: preg nant wome n who responded “no” “not sure” and “not 
now, need more inform aon” to “Do you want to ge t inﬂ uenz a va ccine or not?”
1,072 women approached 
for interview
1,031 (96%) completed 
survey quesi tonnai re
627 (61%) had heard 
about inﬂuenza vacc ine 
(analycal  sam ple)
262 (42%) willing to 
recei ve the vac cinea
365 (58%) not willi ng to 
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accine during the current pregnancy (PR 1.3, 95% CI 1.2–1.5) than
omen who had not heard of the vaccine (Supplemental Table 2).
Among women familiar with inﬂuenza vaccine, the median age
as 27 years (inter-quartile range [IQR] 22–31 years) and median
estational age at time of interview was 28 weeks (IQR 17–35
eeks). The average household income in our survey was  15,767
hai Baht per month (493 U.S. dollars) and almost half of partic-
pants were earning less than 10,000 Baht (313 U.S. dollars) per
onth. Most of the participants were married (97%), 50% worked
utside the home, and 98% had health insurance through the
able 1
escriptive characteristics of pregnant women by willingness to be vaccinated, Thailand,
Factors Willing to be
vaccinated N (%)
(n = 262)
Age (years)
15–24 116 (44) 
25–34  112 (43) 
35–45  34 (13) 
Gestational age (weeks)
First trimester (1–13 weeks) 47 (18) 
Second trimester (14–27 weeks) 88 (34) 
Third  trimester (>27 weeks) 127 (48) 
Married 253 (97) 
Highest level of education
None or primary 32 (12) 
Secondary school 174 (66) 
Diploma or higher 56 (21) 
Household income <10,000 Baht per month 149 (57) 
Work  outside of home 120 (45) 
Health insurance that covered inﬂuenza vaccination 257 (98) 
Received inﬂuenza vaccine during previous pregnancy 50 (19) 
Received inﬂuenza vaccine during current Pregnancy 25 (9.5) ant women  survey.
Universal Coverage Scheme. Sixty-three (10%) pregnant women
had received inﬂuenza vaccine during a previous pregnancy and
25 (4%) had received it during their current pregnancy.
Two  hundred and sixty-two (42%) women reported being
willing to receive the seasonal inﬂuenza vaccine (Fig. 1). Most
demographic characteristics were similar between women willing
and not willing to receive the inﬂuenza vaccination (Table 1), but
women who had received an inﬂuenza vaccine during a previous
pregnancy were twice as likely to be willing to receive an inﬂuenza
vaccine during the current pregnancy (PR 2.1, 95% CI 1.8–2.5).
 2013.
Not willing to be
vaccinated N (%)
(n = 365)
Prevalence ratio 95% conﬁdence
interval
133 (36) 1.0 –
185 (51) 0.8 0.7–1.0
47 (13) 0.9 0.7–1.2
59 (16) 1.0 –
118 (32) 1.0 0.7–1.3
188 (52) 0.9 0.7–1.2
356 (98) 0.8 0.8–1.3
48 (8) 1.0 –
222 (61) 1.1 0.8–1.5
95 (26) 0.9 0.7–1.3
174 (48) 1.2 1.0–1.5
193 (53) 1.1 0.9–1.4
356 (98) 1.2 0.6–2.4
13 (4) 2.1 1.8–2.5
– – –
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Table 2
Comparison of the proportion of pregnant women who agreed with various health beliefs by willingness to receive the inﬂuenza vaccination, Thailand, 2013 (N = 627).
Health Belief Model Construct Item Wording Willing to be
vaccinated
(n = 262)
Not willing to be
vaccinated
(n = 365)
PRc P-valued
% Agreeda % Agreeda
Perceived
susceptibilityb
Susceptible to
inﬂuenza
I am moderately or very concerned
about getting inﬂuenza
41.6 27.9 1.4 <0.001
I  am moderately or very concerned
about my unborn baby getting
inﬂuenza
27.1 18.4 1.3 0.009
Perceived severityb Inﬂuenza more severe
in pregnancy
If a pregnant woman gets inﬂuenza,
she is more likely to have severe illness
compared to the general public
70.6 57.3 1.4 0.001
Harm baby If a pregnant woman gets inﬂuenza,
the illness could harm her unborn baby
76.3 69.3 1.2 0.053
Perceived barriersb Vaccine causes illness Inﬂuenza vaccine can cause a person to
get sick with inﬂuenza
9.9 10.4 1.0 0.842
Vaccine not safe Inﬂuenza vaccine is not safe during
pregnancy
4.6 4.4 1.0 0.906
Vaccine not effective Inﬂuenza vaccine is not an effective
way  to prevent a pregnant woman
from getting sick with inﬂuenza
2.3 2.5 1.0 0.887
Perceived beneﬁtsb Protects unborn/new
born baby
Giving inﬂuenza vaccine to a pregnant
woman  will beneﬁt her fetus and new
born baby
78.2 52.1 2.1 <0.001
Protects child Inﬂuenza vaccine could protect the
baby during the ﬁrst months of life
77.9 52.6 2.1 <0.001
Protects women Getting inﬂuenza vaccine during
pregnancy is a beneﬁt for the pregnant
woman
82.8 53.2 2.5 <0.001
Cues  to actionb MOPH If MOPH recommended inﬂuenza
vaccine for pregnant women I would
get vaccinated
74.0 34.2 2.8 <0.001
Relatives If relative recommended inﬂuenza
vaccine for pregnant women I would
get vaccinated
58.8 19.5 2.5 <0.001
Husband If husband recommended inﬂuenza
vaccine for pregnant women I would
get vaccinated
60.3 20.3 2.6 <0.001
Healthcare provider If nurse recommended inﬂuenza
vaccine for pregnant women I would
get vaccinated
77.1 48.8 2.2 <0.001
If  physician recommended inﬂuenza
vaccine for pregnant women I would
get vaccinated
86.6 64.7 2.3 <0.001
a The % agreed was calculated from frequency of participant who  answered “agree” or “Moderate and very much concerned (likely)” after we recoded scale (see Supplemental
Table  1).
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c PR = prevalence ratio.
d P-value based on chi-square test.
.2. Health beliefs of pregnant women and willingness to be
accinated
Perceived susceptibility to inﬂuenza, severity of inﬂuenza, ben-
ﬁts of inﬂuenza vaccine and cues to action were higher among
omen who were willing to be vaccinated than those who were not
Table 2). Among women willing to be vaccinated, 42% perceived
hemselves as susceptible to inﬂuenza compared with 28% of
omen unwilling to be vaccinated (P < 0.001). A greater propor-
ion of pregnant women who were willing to be vaccinated than
hose not willing believed the inﬂuenza vaccine would protect their
nborn child (78% vs. 52%, P < 0.001) or themselves (83% vs 53%,
 < 0.001). Women  willing to be vaccinated were much more likely
han women unwilling to be vaccinated to respond to cues to action
o be vaccinated from the MOPH (74% vs. 34%, P < 0.001), relatives
59% vs. 20%, P < 0.001), husband (60% vs. 20%, P < 0.001), nurse (77%
s. 49%, P < 0.001) and physicians (87% vs. 65%, P < 0.001).
In univariate models, high levels of perceived susceptibility of
nﬂuenza illness, high levels of perceived beneﬁts of vaccination,and moderate and high levels of cues to action were positively
associated with willingness to receive the inﬂuenza vaccine, while
perceived barriers of vaccination were negatively associated with
willingness to be vaccinated in pregnant women (Table 3). In the
ﬁnal model, moderate (PR 1.5 95% CI 1.1–2.0) and high (PR 2.7 95%
CI 2.0–3.6) level of cues to action were statistically associated with
willingness to be vaccinated (Table 3).
4. Discussion
We  surveyed pregnant women receiving antenatal care at public
clinics in Thailand as part of a national inﬂuenza vaccine program
evaluation. Our evaluation suggests that two  out of three pregnant
women had heard about the inﬂuenza vaccine but <5% of women
who had heard about the vaccine received it during their cur-
rent pregnancy. Although vaccine uptake was low, 42% of women
who were familiar with the inﬂuenza vaccine said they would be
willing to be vaccinated. Cues to action such as recommendations
for vaccination from healthcare providers, relatives and husbands
D. Ditsungnoen et al. / Vaccine 34 (2016) 2141–2146 2145
Table  3
Prevalence ratios for association between Health Belief Model constructs and willingness to receive the inﬂuenza vaccination among pregnant women  in Thailand, 2013
(N  = 627).
Health belief model construct Willing to be
vaccinated (n = 262)
Not willing to be
vaccinated (n = 365)
Unadjusted Adjustedc
N (%) N (%) PRa 95% CIb PRa 95% CIb
Perceived susceptibility
Low (Reference) 67 (25) 121 (33) 1.0 –
Moderate 109 (42) 170 (47) 1.1 0.9–1.4
High  86 (33) 74 (20) 1.5 1.2–2.0
Perceived severity
Low (Reference) 105 (40) 180 (49) 1.0 –
High 157(60) 185 (51) 1.2 1.0–1.6
Perceived barriers
Low (Reference) 166 (64) 137 (37) 1.0 – 1.0 –
Moderate 64 (24) 153 (42) 0.5 0.4–0.7 0.8 0.6–1.0
High  32 (12) 75 (21) 0.5 0.4–0.8 0.9 0.7–1.2
Perceived beneﬁts
Low (Reference) 57 (22) 174 (48) 1.0 – 1.0 –
Moderate 35 (13) 61 (17) 1.5 1.0–2.1 1.2 0.9–1.6
High  170 (65) 130 (35) 2.3 1.7–3.1 1.4 1.0–1.9
Cues  to action
Low (Reference) 37 (14) 141 (38) 1.0 – 1.0 –
Moderate 89 (34) 170 (47) 1.7 1.2–2.3 1.5 1.1–2.0
High  136 (52) 54 (15) 3.4 2.6–4.5 2.7 2.0–3.6
a PR, prevalence ratio derived from a log-binomial model.
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c Adjusted for other variables in the model.
ere independently associated with willingness to be vaccinated
mong Thai pregnant women after adjusting for other variables.
lthough in univariate models, perceived susceptibility to inﬂuenza
nd perceived beneﬁts to inﬂuenza vaccination were associated
ith greater willingness to be vaccinated in pregnant women, and
erceived barriers were associated with lower willingness to be
accinated, these associations were no longer statistically signiﬁ-
ant after adjusting cues to action.
Although the Thai Advisory Committee on Immunization Prac-
ices expanded inﬂuenza vaccine recommendations to include
regnant women  as a high priority group in 2009, seasonal
nﬂuenza vaccine coverage among Thai pregnant women  was
eported to be only 0.9–1.1% during 2010–2012, and much lower
han other high risk groups [14]. Vaccination coverage among Thai
regnant women may  be low for several reasons. First, access may
e insufﬁcient, since national inﬂuenza vaccine supplies are limited
nd are determined by estimates of the number of persons with
hronic diseases without accounting for pregnant women as a sep-
rate risk group. Each year, the Thai government purchases 3.5
illion doses of vaccine, whereas the population of Thailand is 66
illion with approximately 10 million persons with chronic dis-
ase and 700,000 pregnant women [14]. Thus, the government may
ish to consider the number of pregnant women each year when
urchasing inﬂuenza vaccine to increase inﬂuenza vaccine cover-
ge. Second, we found that healthcare provider recommendations
ere an important cue to action for inﬂuenza vaccine acceptance
mong Thai pregnant women, but only 25% of pregnant women
ad received a healthcare provider recommendation for inﬂuenza
accination. Improving access to inﬂuenza vaccines by increas-
ng the supply of government-funded vaccine available each year
nd increasing healthcare provider awareness of the importance
f recommending inﬂuenza vaccination to pregnant women might
ncrease vaccination coverage rates among Thai pregnant women.HBM theory provides a valuable framework for evaluating fac-
ors associated with vaccination behavior. Using the HBM model,
e found that cues to action were the most important factors asso-
iated with willingness to receive inﬂuenza vaccine. Prior studieshave identiﬁed healthcare providers’ recommendations as an
important cue to action for pregnant women  to receive inﬂuenza
vaccine [22,23]. A study by Geraldine and colleagues demonstrated
that the factors associated with higher rate of vaccination during
the inﬂuenza A (H1N1) 2009 pandemic were vaccination occurring
toward the end of pregnancy, and conﬁdence in advice offered by
health professionals [23]. In our study population, a recommen-
dation for vaccination from a family member or husband was also
an important cue to action suggesting that vaccination campaigns
could also target family members as well as pregnant women
themselves in order to increase vaccination coverage.
Surprisingly, after accounting for cues to action, potential barri-
ers to inﬂuenza vaccination, including safety concerns and lack of
conﬁdence in the effectiveness of the vaccine, were not important
predictors of willingness to be vaccinated in our survey. This ﬁnding
is in contrast with several previous studies of pregnant women  con-
ducted in Western countries [24–26]. In the Georgia Pregnancy Risk
Assessment and Monitoring System, unvaccinated respondents
cited a variety of reasons for not receiving the inﬂuenza vaccine
including worries that the vaccine might harm their babies (27%)
or themselves (26%) [27]. Similarly, in a cross-sectional survey of
pregnant women  at an academic, tertiary care hospital in Penn-
sylvania, 61% of the women  reported concern about vaccine safety
during pregnancy and 8% reported the belief that the inﬂuenza vac-
cine caused inﬂuenza [28]. As perceived barriers were associated
with lower willingness to be vaccinated in univariate models, it is
likely that conﬁdence in recommendations of healthcare providers
and family members overrides any personal concerns about safety
or effectiveness.
Our evaluation had several limitations. First, the survey was not
a probability sample, and therefore it is unclear how representative
the sample is of the pregnant Thai population. Our ﬁnding of a much
higher rate of vaccination in this sample than in national estimates
suggests that our sample was more interested and knowledgeable
of the inﬂuenza vaccine than the general population. Second, our
evaluation was  conducted only in public hospitals, and therefore,
our survey population may  not be representative of Thai pregnant
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omen who receive antenatal care at private hospitals or sub-
istrict hospitals and women who do not receive antenatal care.
 survey of Health Behaviors during pregnancy and breastfeed-
ng in Thailand in 2013 found that 71% pregnant women  received
ntenatal care at public hospital, 4% at private hospital, 17% at pri-
ate clinic, and 8% at sub-district health promotion hospital [29].
 report from the National Statistics Ofﬁce found that the propor-
ion of Thai pregnant women who received antenatal care at least
our times during their pregnancy was 93% [30]. Finally, our eval-
ation was not conducted during the inﬂuenza vaccine campaign
eriod (May to September), so the answers from this survey may
ot reﬂect beliefs one would encounter during periods when the
accine is being promoted.
. Conclusions
In this survey 39% of pregnant women had never heard of the
nﬂuenza vaccine and only one in 25 received the vaccine dur-
ng the current pregnancy. Cues to action such as a healthcare
rovider, relative or husband recommendation to get the vac-
ination were important to a pregnant women’s willingness to
eceive the inﬂuenza vaccine. These ﬁndings suggest that improve
ommunication strategies directed toward pregnant women, their
amilies and their providers are needed during vaccine campaigns
n Thailand.
isclaimer
The ﬁndings and conclusions in this report are those of the
uthors and do not necessarily represent the views of the Centers
or Disease Control and Prevention.
onﬂict of interest statement
None.
cknowledgements
This survey was partially supported by the Centers for Disease
ontrol and Prevention (CDC) was awarded to the Ministry of Public
ealth, Thailand in cooperative agreement #5U2GGH000616-02.
he authors would like to give special thanks to interview team
f Dr. Kreingkrai Presert, Ms.  Patcharaporn Somtone and Mr.  Pisit
ereethampitak from Nakhon Phanom Public Health Ofﬁce, Nakhon
hanom Province and Ms.  Kesinee Meesab and Ms.  Anyarat Tham-
aroen from National Vaccine Institute, Ministry of Public Health
nd to the hospital directors. Additionally, we express our deepest
ratitude to all of participant who provided important information.
ppendix A. Supplementary data
Supplementary data associated with this article can be found, in
he online version, at http://dx.doi.org/10.1016/j.vaccine.2016.01.
56.eferences
[1] Henninger M,  et al. Predictors of seasonal inﬂuenza vaccination during preg-
nancy. Am College Obstet Gynecol 2013;121(4):741–9.
[ 34 (2016) 2141–2146
[2] Goldfarb I, et al. Uptake of inﬂuenza vaccine in pregnant women during the
2009 H1N1 inﬂuenza pandemic. Am J Obstet Gynecol 2011;204(6):S112–5.
Supplement to June.
[3] Ward KA, Spokes PJ, McAnulty JM.  Case–control study of risk factors
for hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis
2011;17(8):1409–16.
[4] Jamieson DJ, et al. H1N1 2009 inﬂuenza virus infection during pregnancy in the
USA. Lancet 2009;374(9688):451–8.
[5] Louie JK, et al. Severe 2009 H1N1 inﬂuenza in pregnant and postpartum women
in California. N Engl J Med  2010;362(1):27–35.
[6] Archer N, et al. Interim report on pandemic H1N1 inﬂuenzavirus infections in
South Africa, April to October 2009: epidemiology and factors associated with
fatal cases. Euro Surveill 2009;14(42):p11=19369.
[7] Harper SA, et al. Diagnosis, treatment, chemoprophylaxis, and institutional
outbreak management: clinical practice guidelines of the infectious diseases
society of America. Clin Infect Dis 2009;48(8):1003–32.
[8] Thompson MG, et al. Effectiveness of seasonal trivalent inﬂuenza vaccine for
preventing inﬂuenza virus illness among pregnant women: a population-based
case-control study during the 2010–2011 and 2011–2012 inﬂuenza seasons.
CID 2014;58(4):449–57.
[9] Lier AV, et al. Acceptance of vaccination during pregnancy: experience
with 2009 inﬂuenza A (H1N1) in the Netherlands. Vaccine 2012;30(18):
2892–9.
10] Zaman K, et al. Effectiveness of maternal inﬂuenza immunization in mothers
and infants. N Engl J Med  2008;359(15):1555–64.
11] Eick AA, et al. Maternal inﬂuenza vaccination and effect on inﬂuenza virus
infection in young infants. Arch Pediatr Adolesc Med  2010 2012;165(2):
104–11.
12] Poehling A, et al. Impact of maternal immunization on inﬂuenza hospital-
izations in infants. Am J Obstet Gynecol 2011;204(Supplement to June):
S141–8.
13] Black SB, et al. Effectiveness of inﬂuenza vaccine during pregnancy in preven-
ting hospitalizations and outpatient visits for respiratory illness in pregnant
women  and their infants. Am J Perinatol 2004;21(6):333–9.
14] Owusu JT, et al. Seasonal inﬂuenza vaccine coverage among high-risk popula-
tions inThailand, 2010–2012. Vaccine 2014;33(5):742–7.
15] National Vaccine Institute. The guidelines of the national vaccine insti-
tute steering committee and steering sub-committee; 2010. Available
from: 〈http://nvi.ddc.moph.go.th/attach/e-book/update%20ﬁle/executive/
executive.pdf〉.
16] Saha S, et al. Inﬂuenza seasonality and vaccination timing in tropical and sub-
tropical areas of southern and south-eastern Asia. Bull World Health Organ
2014;92(5):313–30.
17] Glanz K, Rimer KB, Viswanath K. Health behavior and health education: the-
ory, research, and practice. 4th ed San Francisco, CA: Joey-Bass; 2008. p.
45–65.
18] Chen MF,  et al. Using the Health Belief Model to understand caregiver fac-
tors inﬂuencing childhood inﬂuenza vaccinations. J Community Health Nurs
2011;28(1):29–40.
19] Gorman RJ, et al. Theory-based predictors of inﬂuenza vaccination among
pregnant women. Vaccine 2012;31(1):213–8.
20] Moalosh R, et al. Factor associated with inﬂuenza vaccine receipt in community
dwelling adults and their children. Vaccine 2014;32(16):1841–7.
21] Pan W.  Akaike’s information criterion in generalized estimating equations. Bio-
metrics 2001;57(1):120–5.
22] Yuen CYS, Tarrant M.  Determinants of uptake of inﬂuenza vaccination among
pregnant women—a systematic review. Vaccine 2014;32(36):4602–13.
23] Geraldine BR, Claire AS. Vaccination during pregnancy to protect infants against
inﬂuenza: why and why not? Vaccine 2011;29(43):7542–50.
24] Silverman NS, Greif A. Inﬂuenza vaccination during pregnancy: patients’ and
physicians’s attitudes. J Reprod Med  2001;46(11):989–94.
25] Valerie IS, et al. Inﬂuenza immunization in pregnancy: overcoming patient and
health care provider barriers. Am J Obstet Gynecol 2012;207(3):S67–74.
26] Munoz FM,  Englund JA. Vaccines in pregnancy. Infect Dis Clin North Am
2001;15(1):253–71.
27] Ahluwalia IB, et al. Correlates of seasonal inﬂuenza vaccine coverage
among pregnant women in Georgia and Rhode Island. Obstet Gynecol
2010;116(4):949–55.
28] Moniz MH, et al. Perceptions and acceptance of immunization during preg-
nancy. J Reprod Med 2013;58(9–10):383–8.
29] Waleewong O, et al. Health behaviors during pregnancy and breastfeeding;154/chapter1.pdf〉 (cited 2015 November 25).
30] National Statistics Ofﬁce. Thailand multiple indicator cluster Survey,
2012; 2013. Available from: 〈http://service.nso.go.th/nso/nsopublish/themes/
ﬁles/child-womenRep55.pdf〉 (cited 2015 November 25).
